Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full

/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...

Related Keywords

United States , Copenhagen , Køavn , Denmark , Netherlands , Holland , America , Dutch , Robertg Shawah , Ursula Theuretzbacher , Robertj Deluccia , Davidp Luci , Kevin Garey , Nasdaq , Acurx Pharmaceuticals , Anaerobe Society Of America , Acurx Pharmaceuticals Inc , Leiden University Medical Center Holland , European Congress , Prnewswire Acurx Pharmaceuticals Inc , Society Or Healthcare Epidemiology Of America , Drug Administration , Trial Oversight Committee , Data Monitoring Committee , Diseases Society Of America , Exchange Commission On Form , Exchange Commission , University Of Houston College Pharmacy , University Of Houston , Investigational New Drug Application , Independent Data Monitoring Committee , Leiden University Medical Center , Anaerobe Society , Clinical Microbiology , Infectious Disease , Houston College , Principal Investigator , Executive Chairman , Full Year , Chief Executive Officer , Chief Financial Officer , Ibezapolstat Phase , Bile Acid , Clinical Practice Guidelines , Diseases Society , Healthcare Epidemiology , New England Journal , England Journal , Private Securities Litigation Reform Act , United States Food , Looking Statements , Chief Executive , Paycheck Protection Program , Nc ,